Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

被引:0
作者
Nicholas H. B. Schräder
Emily S. Gorell
Roy E. Stewart
José C. Duipmans
Nicole Harris
Victoria A. Perez
Jean Y. Tang
André P. Wolff
Marieke C. Bolling
机构
[1] University Medical Centre Groningen,Department of Dermatology
[2] University of Groningen,Department of Dermatology
[3] University of Cincinnati College of Medicine,Department of Dermatology
[4] Stanford University School of Medicine,Department of Health Sciences, Community and Occupational Medicine
[5] University of Groningen,Anaesthesiology Pain Centre, Department of Anaesthesiology
[6] University Medical Centre Groningen,undefined
[7] Columbia University School of Medicine,undefined
[8] University Medical Centre Groningen,undefined
[9] University of Groningen,undefined
来源
Orphanet Journal of Rare Diseases | / 16卷
关键词
Epidermolysis bullosa; Cannabinoid-based medicines; Symptom alleviation; Patient driven research; Genodermatoses; Survey; Pain; Itch; Wounds;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 299 条
[1]  
Has C(2020)Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility Br J Dermatol 183 614-627
[2]  
Bauer JW(2013)Inherited epidermolysis bullosa: clinical and therapeutic aspects An Bras Dermatol 88 185-198
[3]  
Bodemer C(2019)Impact of painful wound care in epidermolysis bullosa during childhood: an interview study with adult patients and parents Acta Derm Venereol 99 783-788
[4]  
Bolling MC(2014)Pain care for patients with epidermolysis bullosa: best care practice guidelines BMC Med 12 178-201
[5]  
Bruckner-Tuderman L(2021)Prevalence, pathophysiology and management of itch in epidermolysis bullosa Br J Dermatol 184 816-825
[6]  
Diem A(2015)Prevalence and characterization of pruritus in epidermolysis bullosa Pediatr Dermatol 32 53-59
[7]  
Boeira VLSY(2018)Self-initiated use of topical cannabidiol oil for epidermolysis bullosa Pediatr Dermatol 35 e224-e227
[8]  
Souza ES(2019)Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases Br J Dermatol 180 922-924
[9]  
Rocha BO(2019)Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa Br J Dermatol 180 711-712
[10]  
Oliveira PD(2006)The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389-462